Webinars
Available On Demand
Join Leslie Orne, President and CEO at Trinity Life Sciences, as she discusses how Trinity is helping life sciences companies launch in Europe at the Jefferies London Healthcare Conference.
Key Topics:
Trinity’s data-driven and insight-driven approach to support clients across their commercial journey.
Trinity’s expertise in helping clients plan market access, evaluate strategic options, develop a shortlist of partners and optimize their approach.
How Trinity’s local team in Europe can bring in-depth expertise, local language, regulatory experience and in-market experience…
Watch Now
White Papers
The pricing and market access (P&MA) landscape in China has been rapidly evolving as the country continuously attempts to balance rewarding innovation and sustainability of healthcare funding. China represents a unique and dynamic market archetype for manufacturers especially in terms of P&MA strategies.
China’s aging population (≥60 years) is estimated to exceed 400 million by 2035 driving a significant rise in government healthcare expenditure and medical insurance subsidies in the future. As such, the Chinese government has acknowledged the important…
Read Now
Webinars
Available On Demand
In Part 1 of this webinar series, The Path to Launch, we discussed various pathways and innovative programs to accelerate product launch in China. However, launching a product is only half of the battle. Ensuring optimal access to deliver the treatment to more patients is also critical for commercial success.Join Trinity Life Sciences’ APAC experts for Part 2 as they decode recent key pricing and access dynamics in the China pharmaceutical market and explore what strategies and levers are available to…
Watch Now
Briefs
Rare diseases present unique challenges to companies looking to commercialize treatments.
Although there is vast potential in rare disease, each space is different and unique.
Companies must effectively address challenges around identifying and treating patients—as well as providing long-term support. It is critical that companies understand the nuances in each disease.
Keeping a patient-first mentality, advancing patients’ needs and providing excellent support services are mission-critical for life sciences companies touching rare disease. However, lack of disease awareness and unclear referral…
Read Now
Blog
Published October 12, 2023
Recently Trinity Life Sciences’ team members had the opportunity to attend the Intellus Worldwide Institute in Boston. The institute featured interactive discussions about topics impacting health insights and analytics, including the evolving payer landscape, increasing importance of patient segmentation and growing role of AI in healthcare.
Evolving Payer Research Landscape
Discussions about the payer research landscape centered on the importance of increasing the visibility of payer insights across research phases and brand verticals, especially in light of greater cost consciousness. …
Read Now
White Papers
Share estimates from demand studies in primary market research (PMR) are a critical input for any forecast—their accuracy is paramount for successful brand planning.
Successful prediction is often elusive—from 2020 through 2022, only one in ten products had actual performance that aligned with forecasted expectations.*
Recognizing this challenge, Trinity experts developed a method that significantly improves prediction of future prescribing behavior in demand studies.
The Challenge
It is often difficult for Healthcare Professionals (HCPs) to offer precise share estimates when…
Read Now
Webinars
Available On Demand
Most of today’s newest methods rely on large amounts of disparate and multi-sourced data.
Data integration is the next innovation:
Speeding the ingestion of valuable data sets
Quality checking and cataloging data for downstream business applications
Supporting data-driven decisions and business data needs quickly
Trinity Terra is a foundational data management tool, built for life sciences companies to enable rapid, intuitive data transformation. Hundreds of data extractors for commonly used data sources and easy data stitching allow users to…
Watch Now
Webinars
Available On Demand
How can companies maximize their potential when launching a gene therapy product?
Gene therapy commercialization is in its infancy. Limited commercial precedent creates significant difficulty in modeling gene therapy revenue and uptake. The single administration nature of the products also presents a unique challenge for companies as the eligible patient population decreases over time.
In this webinar, Trinity Life Sciences’ cell and gene therapy experts evaluate the factors that are unique to forecasting gene therapy markets and share what companies…
Watch Now
Webinars
Available On Demand
Siloed approaches and communication problems are common hurdles that leaders focused on Incentive Compensation (IC) in life sciences face. Complex and proliferating data streams are another. Join Susheel Sukhtankar, Partner & Head of Commercial Analytics, as he hosts panelists Cheryl Crawford, SVP of Data Management & Commercial Operations, Jim Castello, VP of Field Operations & Incentive Compensation and Ed Bach, Principal.
Key Webinar Topics
Communicating seamlessly—alignment between leadership, home office and field teams
Leveraging appropriate data—identification, evaluation and integration
Proactive…
Watch Now
White Papers
Trinity Life Sciences has been tracking and analyzing the challenges of commercialization and new product launches in the Biopharma industry for years (see our 2022 white paper, Empowering the Next-Generation Launch Model). One method we have leveraged to track the challenges in commercialization is new product launch performance, comparing first calendar year actual sales with consensus Wall Street analyst forecast estimates at time of launch for novel product (New Molecular Entities) launches within the U.S.
In this white paper, we…
Read Now
